Clinical importance of microbleeds in patients receiving IV thrombolysis

Completed

Phase N/A Results

Summary of Purpose

To determine if microbleeds (MBs) detected on gradient echo (GRE) imaging may be a risk factor for hemorrhagic complications in patients with stroke treated with IV tissue plasminogen activator (tPA).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 May 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • NIH

Trial Design

Multi-center, open-label, pilot study.

Contacts

  • Dr. W. Kakuda 701 Welch Road, Ste B 325 Palo Alto, CA 94304

    wkakuda@stanford.edu